<DOC>
	<DOCNO>NCT01669876</DOCNO>
	<brief_summary>To explore whether dietary supplementation version Anatabloc ( R ) exert effect blood level amyloid beta ( AÎ² ) , impact global functional measure Alzheimer 's Disease ( AD ) subject mild moderate AD .</brief_summary>
	<brief_title>Study Evaluate Dietary Supplementation With Version Anatabloc ( R ) Subjects With Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>At least 65 year old . Have diagnosis probable AD concurrent diagnosis probable AD possible probable vascular dementia . Score 16 MiniMental State Examination ( MMSE ) . Otherwise stable medical history general health . Weigh 45 kg 120 kg inclusive . Have contraindication , allergy , sensitivity study product component . Be currently take follow medication : systemic ( oral injectable ) glucocorticoid ; interferonalpha ; antiCD20 antibody ( e.g. , rituximab ) ; antiCTLA4 antibody ( e.g. , ipilimumab ) . Be current smoker smokeless tobacco user .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Randomized</keyword>
	<keyword>Double-Blind</keyword>
	<keyword>Dietary Supplements</keyword>
</DOC>